Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Active, not recruiting · NCT03333616 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Genitourinary Cancer, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, endocrine system disorder, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm, small cell carcinoma | Active, not recruiting | Phase 2 | 2026-07-23 | NCT03333616 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Dana-Farber Cancer Institute | 324 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 45 |
| Dana-Farber Cancer Institute | Boston | United States | 68 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| University of California, San Diego Moores Cancer Center | La Jolla | United States | 5 |
| Winship Cancer Institute, Emory University | Atlanta | United States | 47 |